🇺🇸 FDA
Patent

US 11242400

CD123 binding proteins and related compositions and methods

granted A61KA61K2039/505A61K2039/545

Quick answer

US patent 11242400 (CD123 binding proteins and related compositions and methods) held by Aptevo Research and Development LLC expires Mon Feb 03 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Aptevo Research and Development LLC
Grant date
Tue Feb 08 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 03 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
33
CPC classes
A61K, A61K2039/505, A61K2039/545, A61P, A61P35/00